» Emergency type

Ivermectin for onchocercal eye disease (river blindness)

Read the full article
Ivermectin can prevent damage to the front of the eye but its effectiveness in preventing blindness remains uncertain.
Onchocerciasis causes severe itching and thickening of the skin, and damages structures at the front and back of the eye. It also affects the nerve …

Full Story »

Corticosteroids for dengue infection

Read the full article
There is insufficient evidence to justify the use of corticosteroids in managing dengue shock syndrome. As corticosteroids can potentially do harm, clinicians should not use them unless they are participating in a randomized controlled trial comparing corticosteroids with placebo.
Dengue virus is …

Full Story »

Vaccines for preventing typhoid fever

Read the full article
The licensed Ty21a and Vi polysaccharide vaccines are efficacious. The new and unlicensed Vi-rEPA vaccine is as efficacious and may confer longer immunity.
Two typhoid vaccines are commercially available, Ty21a (oral) and Vi polysaccharide (parenteral), but neither is used routinely. Other vaccines, such …

Full Story »

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)

Read the full article
Trials were small and methodological quality varied. In adults, fluoroquinolones may be better for reducing clinical relapse rates compared to chloramphenicol. Data are limited for other comparisons, particularly in children.
Fluoroquinolones are recommended as first-line therapy for typhoid and paratyphoid fever (enteric fever), …

Full Story »

Antibiotic therapy for Shigella dysentery

Read the full article
We recommend the use of antibiotics for moderate to severe Shigella dysentery. The choice of antibiotic to use as first line against Shigella dysentery should be governed by periodically updated local antibiotic sensitivity patterns of Shigella isolates. Other supportive and preventive measures …

Full Story »

Drugs for treating Schistosomiasis mansoni infection

Read the full article
The available evidence supports single dose praziquantel at 40 mg/kg as standard treatment for S. mansoni infection as recommended by the WHO. Oxamniquine, a largely discarded alternative, appears efficacious and production and distribution should continue to ease selective pressure on praziquantel. However, …

Full Story »

Drugs for treating urinary schistosomiasis

Read the full article
Praziquantel and metrifonate are effective treatments for urinary schistosomiasis and have few adverse events. Metrifonate requires multiple administrations and is therefore operationally less convenient in community-based control programmes. Evidence on the artemisinin derivatives is currently inconclusive, and further research is warranted on …

Full Story »

Vaccines for preventing invasive salmonella infections in people with sickle cell disease

Read the full article
It is expected that salmonella vaccines may be useful in people with sickle cell disease, especially in resource-poor settings where the majority of those who suffer from the condition are found. Unfortunately, there are no randomized controlled trials on the efficacy and …

Full Story »

Antimicrobials for treating symptomatic non-typhoidal Salmonella infection

Read the full article
There appears to be no evidence of a clinical benefit of antibiotic therapy in otherwise healthy children and adults with non-severe salmonella diarrhoea. Antibiotics appear to increase adverse effects and they also tend to prolong salmonella detection in stools.
Non-typhoidal salmonellosis appears to …

Full Story »

Immunoglobulins for preventing hepatitis A

Read the full article
Immunoglobulins seem effective for preventing hepatitis A in both children and adults. However, the evidence, on which the conclusion is based, is not strong as the included trials appear to have risk of bias and their number is insufficient.
Hepatitis A is a …

Full Story »